Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients
Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients

NCT01439776

CompletedPhase 4

Sponsor: Hanyang University

Conditions: Chronic Hepatitis C

Interventions: Vit D

Countries: South Korea

Standard therapy for chronic hepatitis C virus (HCV) is (Peg/RBV) combination therapy obtaining sustained virologic response (SVR) in 77% of naïve patients with genotype 1-3 Studies rarely address the issues of improving host factors. The current study examines whether adding vitamin D with Peg/RBV, a potent immunomodulator, could improve viral response(SVR)compared to Peg/RBV.

Eligibility overview

Sex: ALL

Age: 20 Years to 75 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Chronic genotype 1-3 HCV infection
* Treatment Naive

Exclusion Criteria:

* Child B and C
* HCC patients
* Pregnancy
Locations (13)
  • Cheonan, Chungcheongnam-do, South Korea
  • Bucheon-si, Gyeonggi-do, South Korea
  • Guri-si, Gyeonggido, South Korea
  • Seongnam, Gyeonggido, South Korea
  • Chuncheon, Kangwondo, South Korea
  • Wŏnju, Kangwondo, South Korea
  • Seoul, South Korea
  • Seoul, South Korea
  • Seoul, South Korea
  • Seoul, South Korea
  • Seoul, South Korea
  • Seoul, South Korea
  • Seoul, South Korea